Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
FDA DISCLAIMER: Our treatments are off label meaning NOT FDA approved to diagnose, treat, cure, or prevent any condition or disease
Concentration: 10MG/ML Total Volume: 30ML Total Content: 300MG Format: cGMP liquid research prep Compound: Dihexa Available Format 1: 5MG per capsule 60 capsules cGMP finished capsule product Available Format 2: 10MG/ML 30ML cGMP liquid research prep Total Content Per Format: 300MG Dihexa Research Category: Neurotrophic / HGF c-Met pathway research Research Focus: HGF/c-Met signaling, synaptogenic pathway models, neurotrophic signaling, neuronal connectivity, dendritic spine biology, cognitive pathway research, and CNS cellular response systems
Not a single case
Three principal amylin receptor subtypes exist [13] : AMY1 Receptor CTR + RAMP1 Primary receptor in area postrema (brainstem satiety center) [14] AMY2 Receptor CTR + RAMP2 Expressed in cardiovascular tissues and central nervous system [14] AMY3 Receptor CTR + RAMP3 Found in peripheral tissues including gastrointestinal tract [14] Cagrilintide binds to and activates these receptors with high affinity, triggering intracellular signaling cascades involving cyclic AMP (cAMP) and calcium mobilization [4]
Material discussed here is intended strictly for laboratory research use only
